315 related articles for article (PubMed ID: 25039777)
1. Nanotechnology and Alzheimer's disease: what has been done and what to do.
Ruozi B; Belletti D; Pederzoli F; Veratti P; Forni F; Vandelli MA; Tosi G
Curr Med Chem; 2014; 21(36):4169-85. PubMed ID: 25039777
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine for the treatment of Alzheimer's disease.
Gregori M; Masserini M; Mancini S
Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
[TBL] [Abstract][Full Text] [Related]
3. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.
Tosi G; Pederzoli F; Belletti D; Vandelli MA; Forni F; Duskey JT; Ruozi B
Prog Brain Res; 2019; 245():57-88. PubMed ID: 30961872
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
[TBL] [Abstract][Full Text] [Related]
6. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
Panghal A; Flora SJS
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
Shabbir U; Rubab M; Tyagi A; Oh DH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.
Andrieux K; Couvreur P
Ann Pharm Fr; 2013 Jul; 71(4):225-33. PubMed ID: 23835020
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges.
Cano A; Turowski P; Ettcheto M; Duskey JT; Tosi G; Sánchez-López E; García ML; Camins A; Souto EB; Ruiz A; Marquié M; Boada M
J Nanobiotechnology; 2021 Apr; 19(1):122. PubMed ID: 33926475
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
[TBL] [Abstract][Full Text] [Related]
13. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
14. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment.
De Matteis L; Martín-Rapún R; de la Fuente JM
Curr Med Chem; 2018; 25(35):4602-4615. PubMed ID: 29022501
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?
Dabur M; Loureiro JA; Pereira MC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340267
[TBL] [Abstract][Full Text] [Related]
18. Bionanotechnologies for treatment and diagnosis of Alzheimer's disease.
Moghimi SM
Nanomedicine; 2011 Oct; 7(5):515-8. PubMed ID: 21616169
[No Abstract] [Full Text] [Related]
19. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
20. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease.
Ahmad MZ; Ahmad J; Amin S; Rahman M; Anwar M; Mallick N; Ahmad FJ; Rahman Z; Kamal MA; Akhter S
CNS Neurol Disord Drug Targets; 2014; 13(8):1315-24. PubMed ID: 25345516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
